Treatment strategies for patients with severe aplastic anemia
Author:
- 13 August 2008
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 42 (S1) , S42-S44
Abstract
Treatment strategies for patients with severe aplastic anemia (SAA), depend on the severity of the disease, the age of the patient and the availability of a family donor. Progress in the past has included the early use of combined immunosuppressive therapy (IST) and better matching strategies to select unrelated donors. Currently, the actuarial 10-year survival in 2479 patients registered within the European Group for Blood and Marrow Transplantation (EBMT), is 73 and 68% for patients receiving first-line BMT or IST. The outcome of BMT has significantly improved since 1996, and this is true for both matched sibling donor BMT as well as for alternative donor BMT. Survival is significantly better in children (PP=0.001), especially in very severe aplasia (83 versus 62%, P=0.0002). This report outlines some of these results as a basis for treatment strategies in SAA.Keywords
This publication has 22 references indexed in Scilit:
- The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemiaBone Marrow Transplantation, 2006
- Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working PartyBone Marrow Transplantation, 2005
- T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemiaExperimental Hematology, 2005
- Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejectionBone Marrow Transplantation, 2003
- Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiationTransplantation and Cellular Therapy, 2001
- Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experienceSeminars in Hematology, 2000
- Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapyBritish Journal of Haematology, 1999
- Effectiveness of Immunosuppressive Therapy in Older Patients with Aplastic AnemiaAnnals of Internal Medicine, 1999
- Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiationRadiotherapy and Oncology, 1994
- APLASTIC ANÆMIA: EVIDENCE FOR AN IMMUNOLOGICAL MECHANISMThe Lancet, 1976